Close menu




June 24th, 2026 | 08:40 CEST

Alarm at BMW! Sell-off at BioNTech! Desert Gold Undervalued!

  • Mining
  • Gold
  • Africa
  • Commodities
  • Biotechnology
  • Automotive
Photo credits: AI

Alarm at BMW. First, the company shocked shareholders with a profit warning. Now, business in China has collapsed. Analysts are finally reacting by slashing their estimates and price targets. Is it time to buy now? From the perspective of GBC Research, Desert Gold is the stock to buy right now. The company is set to transition from an explorer to a gold producer this summer. Analysts see its intrinsic value well above current price levels. And what about BioNTech? The share has been trading sideways for months. The announcement of location closures has drawn heavy criticism. Shareholders are equally disillusioned. Could rival Moderna, of all companies, now bring hope to the workforce?

time to read: 4 minutes | Author: Fabian Lorenz
ISIN: DESERT GOLD VENTURES | CA25039N4084 | TSXV: DAU , OTCQB: DAUGF , BIONTECH SE SPON. ADRS 1 | US09075V1026 , BAY.MOTOREN WERKE VZO | DE0005190037

Table of contents:


    Desert Gold Significantly Undervalued

    While the gold price holds steady above USD 4,000 per ounce, attractive buying opportunities are emerging in gold stocks. This is because little has changed regarding the fundamental drivers of rising prices for the precious metal. Debt in industrialized nations is climbing to ever-new heights, geopolitical uncertainties persist, and central banks remain on the buying side. Added to this is the fact that the monetary policy leeway for sustainably high interest rates remains limited. In addition to these fundamental developments, another argument in favour of buying Desert Gold shares is that the coming months will be particularly exciting for the company.

    Desert Gold is on the verge of producing gold on its own for the first time using a small gravity plant at the SMSZ project in Mali. With the start of production in the Barani East area, Desert Gold would take the decisive step from being purely an explorer to becoming a potential cash flow generator.

    Launching production via a relatively small-scale operation is a prudent strategic approach. Instead of immediately developing a capital-intensive, large-scale project, Desert Gold can first gain practical experience in mining, processing, logistics, and cost control. At the same time, the financial risk remains manageable. Future production could provide the funds needed to finance drilling programs and resource expansions more independently.

    Furthermore, launching production could position the company as an attractive takeover target. With a resource of approximately 1.2 million ounces of gold, the SMSZ project already has the critical size to be attractive to gold companies. And there is no shortage of gold companies in the region. Allied Gold, Endeavour Mining, Barrick Mining, and B2Gold are active in the vicinity. Incidentally, the SMSZ resource is open in all directions. An upward revision is therefore certainly on the cards.

    Against the backdrop of the start of production, GBC Research recommends buying Desert Gold shares. The price target is CAD 0.93. The stock is currently trading at around CAD 0.12. From the analysts' perspective, the upside potential is therefore significant. The company is currently valued at less than CAD 50 million. Analysts value the Barani East project alone at USD 89.6 million. Overall, they estimate Desert Gold's intrinsic value at USD 244.8 million.

    https://youtu.be/MK7Gjlfn0jg?si=TP5wJJQq2lK5tWGz

    Alarm Bells at BMW

    Alarm bells are ringing at BMW. Over the past four weeks, the stock has lost about 20% of its value. Most recently, an earnings warning triggered a sell-off of over 10%. The company expects a sharper decline in pre-tax profit this year than previously anticipated. The return on investment in the automotive business is also expected to be significantly lower, ranging between just 1% and 3%. Previously, the range was between 4% and 6%. The main factors weighing on the company are a difficult market environment in China, intense price pressure, additional costs stemming from the tense situation in the Middle East, and accelerated cost-cutting measures within the group.

    Analysts have now also reacted to the disaster. Yesterday, Bernstein Research lowered its price target for BMW shares from EUR 108 to EUR 85. Estimates for the current and coming years were reduced. At least the "Outperform" recommendation remained in place, as the stock is currently trading at around EUR 60.

    UBS and Berenberg take a more critical view of the German premium automaker's stock. UBS lowered its price target from EUR 88 to EUR 70. Berenberg estimates the fair value of BMW shares at EUR 69.

    Sell-off at BioNTech

    Is a sell-off beginning at BioNTech? "Reuters" reports that Moderna is exploring investments in German production capacity. The US biotech company is eyeing the sites that BioNTech plans to close as part of its restructuring. Moderna CEO Stéphane Bancel made it clear that an acquisition or partnership could offer advantages over building a facility from scratch. This would require reaching a suitable agreement with the German government. The company is likely speculating on subsidies or tax breaks.

    For BioNTech, selling the facilities would make sense in principle. Following the end of the pandemic boom, the Mainz-based company is scaling back its production capacity focused on COVID-19 vaccines and intends to concentrate more heavily on developing new cancer immunotherapies and other pipeline projects. In May, BioNTech announced it would close several sites in Germany and Singapore. This could affect up to 1,860 jobs. At the same time, the company plans to repurchase up to USD 1 billion in its own shares.

    BioNTech faced significant criticism for these plans, particularly from politicians. The main concern is that, following the experiences of the pandemic, Germany could lose important vaccine production capacity and, in the event of a crisis, once again become dependent on foreign supply chains. Furthermore, questions are being raised as to whether a company that benefited significantly from public support and government trust during the pandemic should now be cutting production sites and jobs so drastically. BioNTech, on the other hand, points to excess capacity for COVID-19 vaccines and its strategic focus on oncology.

    The transaction could be positive for all parties. BioNTech could monetize unused capacity and limit the damage to its reputation. Moderna could gain production capacity more quickly. And jobs would be preserved.

    In recent weeks, BioNTech's share has been trading sideways without much momentum around EUR 80.


    BioNTech's strategy is, in any case, a warning sign for Germany as a business location. Buying shares in Germany's largest biotech company is not compelling at present. In contrast, Desert Gold's attractive valuation makes it an appealing entry point. The GBC study impressively demonstrates that the intrinsic value is significantly higher than the current share price. BMW is currently introducing numerous new electric models. Their success is likely to have a strong influence on the stock's performance.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Fabian Lorenz

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author



    Related comments:

    Commented by André Will-Laudien on November 13th, 2026 | 05:28 CET

    Gold and chip correction, Nvidia in purgatory! Micron Technology, Infineon and DRC Gold in focus

    • Chip sector
    • Gold
    • Critical metals
    • HighTech
    • Artificial intelligence

    Jensen Huang resigns! An unprecedented leadership scandal at AI pioneer Nvidia is keeping international financial markets on tenterhooks and triggering a massive chain reaction. After CEO Jensen Huang admitted to an extramarital affair with a Chinese executive who, according to US intelligence agencies, allegedly worked as a spy for Beijing, a second alleged relationship with a vice-president of the company has now come to light. While the FBI investigates and Nvidia's board of directors considers removing its long-serving visionary, he is taking the consequences himself. The chip giant is losing USD 1 trillion in market value in just 20 trading days. Yet this deep crisis of confidence in the industry leader does not spell the end of the AI boom; instead, it shifts the balance across the entire semiconductor market. Competitors in the chip sector now sense their big chance to wrest valuable market share and data centre orders from the beleaguered market leader. At the same time, the espionage allegations surrounding highly sensitive US processors highlight just how fiercely the technological power struggle between Washington and Beijing is being fought. Even gold, the perennial winner, is stumbling, falling below a key technical level at USD 3,880. Which stocks should investors be watching now?

    Read

    Commented by Carsten Mainitz on November 13th, 2026 | 05:22 CET

    Is the Stock Market Too Pessimistic Here? Lahontan Gold, Aixtron and TeamViewer Under the Microscope

    • Stock Picking
    • Transformation
    • Gold
    • Gold production
    • Exploration
    • AI
    • Technology
    • Software

    Lahontan Gold, Aixtron and TeamViewer have one thing in common: their shares are under pressure. However, their prospects may be better than their current market valuations suggest. While Lahontan Gold is banking on the reopening of a gold mine in Nevada, Aixtron has announced a strategically significant order intake. TeamViewer's lowered revenue guidance, meanwhile, has shaken investor confidence. Investors are increasingly questioning whether the software specialist can translate its sales efforts into new customers and sustainable growth. Where is there genuine share price upside, and where would investors be better off staying on the sidelines?

    Read

    Commented by Armin Schulz on November 12th, 2026 | 05:34 CET

    Micron Technology, Power Metallic Mines and BYD – Copper stocks with tailwinds from AI and electromobility

    • Micron Technology
    • Power Metallic Mines
    • BYD
    • Memory
    • Data centres
    • Copper
    • PGE
    • Gold
    • Silver
    • NISK
    • Electromobility
    • Electric cars
    • Electrification

    Created and Published on Behalf of Power Metallic Mines

    Artificial intelligence and electromobility are simultaneously driving demand for chips and metals. Data centres need memory chips and plenty of copper for power and wiring, while electric vehicles need batteries and copper as well. In early November, Chinese memory manufacturer CXMT reported progress on a new DRAM architecture. Shortly before that, BYD had reported more than 300,000 all-electric vehicles in a single month for the first time in October. If the trend continues, memory chips, copper and electric vehicles will benefit from the same demand. We therefore take a closer look at Micron Technology, Power Metallic Mines and BYD.

    Read